4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-23-009085
Chief Operating Officer sold 3,125 shares at an average $8.60 ($26,863)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ADAMS R MARK Chief Operating Officer | 2023-04-10 | Sale 10b5-1 | −817 | $8.50 | $6,945 | 177,669 | D |
| ADAMS R MARK Chief Operating Officer | 2023-04-11 | Sale 10b5-1 | −2,308 | $8.63 | $19,918 | 175,361 | D |
| Open-market sales · 3,125 sh · avg $8.60 · $26,863 | |||||||
Loading xslF345X04/form4.xml…